Trial Profile
A randomised controlled trial comparing the use of sirolimus based biphasic immunosuppression with myfortic to allow early CalciNeurin Inhibitor (CNI) withdrawal in renal transplantation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Prednisolone (Primary) ; Sirolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Acronyms RMRCTV1
- 06 Oct 2009 New trial record